Business Finland, in cooperation with leading pharmaceutical companies Bayer and Merck, is organizing a delegation visit to their offices in Berlin and Darmstadt. The goal is to showcase Finland’s unique health innovation ecosystem, cutting-edge research, and leading companies in drug discovery, oncology, immunology, health data, and AI. The purpose of the visit is to attract investments to Finland, promote clinical research, and strengthen research and innovation partnerships with key international stakeholders.The visit will take place on September 29–30 and will be led by Dr. Päivi Sillanaukee, Special Envoy for Health and Wellbeing, Ministry of Social Affairs and Health.
This is a unique meeting forum bringing together key personnel from Bayer and Merck headquarters to strengthen cooperation between Finnish and German companies and to identify new business opportunities for Finnish companies.
Who should attend?
The visit is tailored for Finnish companies offering health solutions in drug discovery, oncology, immunology, health data, or AI, and/or seeking partnerships with Bayer and/or Merck.
The delegation is limited to 14 companies, with participation restricted to one representative per company on a first-come, first-served basis.
Practicalities
To cover the expenses, Business Finland will charge a participation fee for arrangements in Germany on 29-30 September 2025
- Major companies: 600 EUR + VAT 25.5% per person
- SMEs and Micro businesses: 510 EUR + VAT 25.5% per person
Business Finland will invoice the participation fee after the visit based on the actual costs. The invoiced fee will not exceed the amounts mentioned above.
